Search Results

Search results for "Federal Circuit", has returned "10" results.

Anything You (are Required to) Say May be Used Against You (as Prior Art): Federal Circuit Upholds Invalidity Based on Mandatory Publication of Clinical Trial Protocol

Federal Circuit Upholds Invalidity Based on Mandatory Publication of Clinical Trial Protocol May 16, 2024 Clinical trials are a critical part of the development and approval process for drugs, biologics,...

Federal Circuit Remands to PTAB to Further Consider Pfizer's Motion to Amend Claims

Federal Circuit Remands to PTAB to Further Consider Pfizer's Motion to Amend Claims March 13, 2024 In a recent ruling regarding Pfizer's pneumococcal vaccine patent (U.S. Patent No. 9,492,559), the ...

Federal Circuit Upholds PTAB Finding of Patentability in Medtronic v. Teleflex Life Sciences

Federal Circuit Upholds PTAB Finding of Patentability in Medtronic v. Teleflex Life Sciences April 1, 2024 In Medtronic, Inc. v. Teleflex Life Sciences Ltd. the Federal Circuit upheld the Patent Trial ...

The Federal Circuit Takes Design Patent Obviousness En Banc

The Federal Circuit Takes Design Patent Obviousness En Banc July 11, 2023 The Federal Circuit on June 30 granted a petition for re-hearing en banc of its per curiam decision in LKQ Corp. v. GM Global ...

Federal Circuit Upholds PTAB Finding of Obviousness in Pfizer vs. Sanofi

Federal Circuit Upholds PTAB Finding of Obviousness in Pfizer vs. Sanofi March 18, 2024 In Pfizer Inc. vs. Sanofi Pasteur Inc., the Federal Circuit upheld the Patent Trial and Appeal Board (PTAB) decision ...

Supreme Court Affirms Federal Circuit Decision in Amgen v. Sanofi

Supreme Court Affirms Federal Circuit Decision in Amgen v. Sanofi May 18, 2023 In a unanimous opinion the Court decided that the Federal Circuit’s decision was correct. The Court noted that that ...

Federal Circuit Reiterates: Isolated Natural Products Alone Are Not Patent Eligible Without A Markedly Different Characteristic

Federal Circuit Reiterates: Isolated Natural Products Alone Are Not Patent Eligible Without A Markedly Different Characteristic March 3, 2023 co-authored by Sara Pistilli, PharmD. and Richard D. Kelly ...

Xiaohua (Joyce) Guo, Ph.D. - Blogs

Ltd, Appeal No. 2024-1061, August 13, 2024, the Federal Circuit reversed the district court’s holding that Allergan patent, U.S.P. 7,741,356 (‘356) was invalid for obviousness-type double patenting ...

The Federal Circuit Rejects PacBio's Argument that Oxford Used the Then-Emerging Global COVID-19 Crisis to Win on Invalidity for Lack of Enablement

The Federal Circuit Rejects PacBio's Argument that Oxford Used the Then-Emerging Global COVID-19 Crisis to Win on Invalidity for Lack of Enablement July 15, 2021 In the recent decision PacificBiosciences ...

NHK-Fintiv Rule Challenges Look Futile at Federal Circuit

NHK-Fintiv Rule Challenges Look Futile at Federal Circuit April 6, 2021 The NHK-Fintiv rule allows the Patent Trial and Appeal Board (PTAB) to deny institution of an inter partes review petition based ...